Last 12 months
Inside the activity.
7 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 1 | 0 |
| Mar 2026 | 5 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 15, 2026 23:26 UTC |
Khoja HamidChief Scientific Officer
|
GrantWarrant (Right to Buy) · Derivative | 298,508 | Not disclosed Strike: $1.55 | Not disclosed |
DisclosureSEC source: 0001493152-26-042794 · ownership.xml · derivative · entry 2 Khoja Hamid · CIK 0002010662 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,508 Underlying: Common Stock · 298,508 shares Expires 2031-09-15 F1 · kind: On September 15, 2026, the reporting person entered into a securities purchase agreement with FibroBiologics, Inc. (the "Company") to purchase 298,508 shares of the Company's common stock, par value $0.00001 per share (the "Common Stock"), and accompanying warrants to purchase up to 298,508 shares of Common Stock (the "Warrants"), in a private placement (the "Offering"). F2 · price: Each share of Common Stock and accompanying Warrant were issued at a combined purchase price of $1.675. F3 · derivative.exercise_date: The warrants are exercisable at any time until they expire. Read SEC document |
| September 15, 2026 Filed Sep 15, 2026 23:26 UTC |
Khoja HamidChief Scientific Officer
|
GrantCommon Stock | 298,508 | $1.68 | $500,000.90 |
DisclosureSEC source: 0001493152-26-042794 · ownership.xml · nonDerivative · entry 1 Khoja Hamid · CIK 0002010662 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 301,571 F1 · kind: On September 15, 2026, the reporting person entered into a securities purchase agreement with FibroBiologics, Inc. (the "Company") to purchase 298,508 shares of the Company's common stock, par value $0.00001 per share (the "Common Stock"), and accompanying warrants to purchase up to 298,508 shares of Common Stock (the "Warrants"), in a private placement (the "Offering"). F2 · price: Each share of Common Stock and accompanying Warrant were issued at a combined purchase price of $1.675. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 00:02 UTC |
Hoffman Robert E.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,803 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-26-029851 · ownership.xml · derivative · entry 1 Hoffman Robert E. · CIK 0001166288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,803 Underlying: Common Stock · 30,803 shares Expires 2036-06-22 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 23, 2026 Filed Jun 23, 2026 23:59 UTC |
Niklas Victoria Ninon OliviaDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,803 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-26-029848 · ownership.xml · derivative · entry 1 Niklas Victoria Ninon Olivia · CIK 0002012250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,803 Underlying: Common Stock · 30,803 shares Expires 2036-06-22 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 00:00 UTC |
Link MatthewDirector
|
GrantStock Option (Right to Buy) · Derivative | 30,803 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-26-029849 · ownership.xml · derivative · entry 1 Link Matthew · CIK 0001565950 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,803 Underlying: Common Stock · 30,803 shares Expires 2036-06-22 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 23, 2026 Filed Jun 24, 2026 00:01 UTC |
Cilento Richard C. Jr.Director
|
GrantStock Option (Right to Buy) · Derivative | 30,803 | $0.00 Strike: $0.75 | $0.00 |
DisclosureSEC source: 0001493152-26-029850 · ownership.xml · derivative · entry 1 Cilento Richard C. Jr. · CIK 0002010661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,803 Underlying: Common Stock · 30,803 shares Expires 2036-06-22 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| May 04, 2026 Filed May 4, 2026 23:00 UTC |
GARCIA RUBEN AGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 61,607 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-021172 · ownership.xml · derivative · entry 1 GARCIA RUBEN A · CIK 0002013617 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,607 Underlying: Common Stock · 61,607 shares Expires 2036-05-04 F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 61,607 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| May 04, 2026 Filed May 4, 2026 23:00 UTC |
Davis JasonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 61,607 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-021173 · ownership.xml · derivative · entry 1 Davis Jason · CIK 0001443533 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,607 Underlying: Common Stock · 61,607 shares Expires 2036-05-04 F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 61,607 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| May 04, 2026 Filed May 4, 2026 23:01 UTC |
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 92,410 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-021175 · ownership.xml · derivative · entry 1 O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,410 Underlying: Common Stock · 92,410 shares Expires 2036-05-04 F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 92,410 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| May 04, 2026 Filed May 4, 2026 23:00 UTC |
Khoja HamidChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 61,607 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001493152-26-021174 · ownership.xml · derivative · entry 1 Khoja Hamid · CIK 0002010662 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,607 Underlying: Common Stock · 61,607 shares Expires 2036-05-04 F1 · derivative.exercise_date: On May 4, 2026, the reporting person was granted an option to purchase 61,607 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods Read SEC document |
| March 04, 2026 Filed Mar 4, 2026 22:50 UTC |
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 15,872 | $0.38 | $6,005.96 |
DisclosureSEC source: 0001493152-26-008903 · ownership.xml · nonDerivative · entry 3 O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,958,147 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 04, 2026 Filed Mar 5, 2026 13:00 UTC |
Khoja HamidChief Scientific Officer
|
PurchaseCommon Stock | 30,000 | $0.38 | $11,400.00 |
DisclosureSEC source: 0001493152-26-008933 · ownership.xml · nonDerivative · entry 1 Khoja Hamid · CIK 0002010662 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,250 Read SEC document |
| March 03, 2026 Filed Mar 4, 2026 22:50 UTC |
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 18,200 | $0.41 | $7,372.82 |
DisclosureSEC source: 0001493152-26-008903 · ownership.xml · nonDerivative · entry 2 O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,942,275 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 02, 2026 Filed Mar 3, 2026 13:00 UTC |
Davis JasonChief Financial Officer
|
PurchaseCommon Stock | 70,000 | $0.41 | $28,973.00 |
DisclosureSEC source: 0001493152-26-008646 · ownership.xml · nonDerivative · entry 1 Davis Jason · CIK 0001443533 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3968 to $0.4200 on March 2, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| March 02, 2026 Filed Mar 4, 2026 22:50 UTC |
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock | 17,428 | $0.35 | $6,152.08 |
DisclosureSEC source: 0001493152-26-008903 · ownership.xml · nonDerivative · entry 1 O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,924,075 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3210 to $0.4166 on March 2, 2026, $0.3885 to $0.4302 on March 3, 2026, and $0.3730 to $0.3820 on March 4, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 14:15 UTC |
GARCIA RUBEN AGeneral Counsel
|
PurchaseCommon Stock | 40,000 | $0.33 | $13,056.00 |
DisclosureSEC source: 0001493152-26-008469 · ownership.xml · nonDerivative · entry 1 GARCIA RUBEN A · CIK 0002013617 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3221 to $0.3268 on February 27, 2026. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 11, 2025 Filed Dec 12, 2025 12:16 UTC |
GARCIA RUBEN AGeneral Counsel
|
PurchaseCommon Stock | 140,000 | $0.34 | $47,600.00 |
DisclosureSEC source: 0001493152-25-027363 · ownership.xml · nonDerivative · entry 1 GARCIA RUBEN A · CIK 0002013617 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $0.3333 to $0.3504 on December 11, 2025. The reporting person will provide upon request to the SEC, the Issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| June 12, 2025 Filed Jun 12, 2025 23:23 UTC |
Hoffman Robert E.Director
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001641172-25-014934 · ownership.xml · derivative · entry 1 Hoffman Robert E. · CIK 0001166288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2025-06-11 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 12, 2025 Filed Jun 12, 2025 23:30 UTC |
Niklas Victoria Ninon OliviaDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001641172-25-014941 · ownership.xml · derivative · entry 1 Niklas Victoria Ninon Olivia · CIK 0002012250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2025-06-11 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 12, 2025 Filed Jun 12, 2025 19:20 UTC |
Coen Stacy AnnDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001641172-25-014931 · ownership.xml · derivative · entry 1 Coen Stacy Ann · CIK 0001814150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2025-06-11 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 12, 2025 Filed Jun 12, 2025 23:26 UTC |
Link MatthewDirector
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001641172-25-014939 · ownership.xml · derivative · entry 1 Link Matthew · CIK 0001565950 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2025-06-11 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 12, 2025 Filed Jun 12, 2025 23:16 UTC |
Cilento Richard C. Jr.Director
|
GrantStock Option (Right to Buy) · Derivative | 22,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001641172-25-014927 · ownership.xml · derivative · entry 1 Cilento Richard C. Jr. · CIK 0002010661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,000 Underlying: Common Stock · 22,000 shares Expires 2035-06-11 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 20:03 UTC |
Davis JasonChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 450,000 | $0.00 Strike: $0.94 | $0.00 |
DisclosureSEC source: 0001641172-25-014512 · ownership.xml · derivative · entry 1 Davis Jason · CIK 0001443533 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2035-06-08 F1 · derivative.exercise_date: On June 9, 2025, the reporting person was granted an option to purchase 450,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| May 27, 2025 Filed May 27, 2025 21:56 UTC |
Khoja HamidChief Scientific Officer
|
PurchaseCommon Stock | 20,000 | $0.84 | $16,800.00 |
DisclosureSEC source: 0001641172-25-012539 · ownership.xml · nonDerivative · entry 1 Khoja Hamid · CIK 0002010662 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,250 Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:10 UTC |
GARCIA RUBEN AGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 189,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001641172-25-001188 · ownership.xml · derivative · entry 1 GARCIA RUBEN A · CIK 0002013617 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,000 Underlying: Common Stock · 189,000 shares Expires 2035-03-25 F1 · derivative.exercise_date: On March 26, 2025, the reporting person was granted an option to purchase 189,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:10 UTC |
O'HEERON PETEDirector · CHIEF EXECUTIVE OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 453,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001641172-25-001189 · ownership.xml · derivative · entry 1 O'HEERON PETE · CIK 0001569334 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 453,000 Underlying: Common Stock · 453,000 shares Expires 2035-03-25 F1 · derivative.exercise_date: On March 26, 2025, the reporting person was granted an option to purchase 453,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| March 26, 2025 Filed Mar 28, 2025 20:10 UTC |
Khoja HamidCHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 189,000 | $0.00 Strike: $1.04 | $0.00 |
DisclosureSEC source: 0001641172-25-001187 · ownership.xml · derivative · entry 1 Khoja Hamid · CIK 0002010662 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,000 Underlying: Common Stock · 189,000 shares Expires 2035-03-25 F1 · derivative.exercise_date: On March 26, 2025, the reporting person was granted an option to purchase 189,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one-year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:18 UTC |
GARCIA RUBEN AGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 176,200 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001493152-24-052488 · ownership.xml · derivative · entry 1 GARCIA RUBEN A · CIK 0002013617 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,200 Underlying: Common Stock · 176,200 shares Expires 2034-12-26 F1 · derivative.exercise_date: On December 27, 2024, the reporting person was granted an option to purchase 176,200 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:21 UTC |
O'HEERON PETEDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 406,339 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001493152-24-052493 · ownership.xml · derivative · entry 1 O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 406,339 Underlying: Common Stock · 406,339 shares Expires 2034-12-26 F1 · derivative.exercise_date: On December 27, 2024, the reporting person was granted an option to purchase 406,339 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| December 27, 2024 Filed Dec 30, 2024 21:20 UTC |
Khoja HamidCHIEF SCIENTIFIC OFFICER
|
GrantStock Option (Right to Buy) · Derivative | 176,200 | $0.00 Strike: $2.36 | $0.00 |
DisclosureSEC source: 0001493152-24-052490 · ownership.xml · derivative · entry 1 Khoja Hamid · CIK 0002010662 · CHIEF SCIENTIFIC OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 176,200 Underlying: Common Stock · 176,200 shares Expires 2034-12-26 F1 · derivative.exercise_date: On December 27, 2024, the reporting person was granted an option to purchase 176,200 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 02:33 UTC |
O'HEERON PETEDirector · Chief Executive Officer
|
GiftCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-049341 · ownership.xml · nonDerivative · entry 1 O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,906,647 Read SEC document |
| December 03, 2024 Filed Dec 5, 2024 22:58 UTC |
O'HEERON PETEDirector · Chief Executive Officer
|
GiftCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-048916 · ownership.xml · nonDerivative · entry 1 O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,006,647 Read SEC document |
| August 27, 2024 Filed Aug 27, 2024 23:53 UTC |
Hoffman Robert E.Director
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001493152-24-034068 · ownership.xml · derivative · entry 1 Hoffman Robert E. · CIK 0001166288 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-08-26 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| August 27, 2024 Filed Aug 27, 2024 23:55 UTC |
Niklas Victoria Ninon OliviaDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001493152-24-034072 · ownership.xml · derivative · entry 1 Niklas Victoria Ninon Olivia · CIK 0002012250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-08-26 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| August 27, 2024 Filed Aug 27, 2024 19:51 UTC |
Coen Stacy AnnDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001493152-24-034066 · ownership.xml · derivative · entry 1 Coen Stacy Ann · CIK 0001814150 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-08-26 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| August 27, 2024 Filed Aug 27, 2024 23:54 UTC |
Link MatthewDirector
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001493152-24-034070 · ownership.xml · derivative · entry 1 Link Matthew · CIK 0001565950 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-08-26 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| August 27, 2024 Filed Aug 27, 2024 23:47 UTC |
Cilento Richard C. Jr.Director
|
GrantStock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001493152-24-034064 · ownership.xml · derivative · entry 1 Cilento Richard C. Jr. · CIK 0002010661 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2034-08-26 F1 · derivative.exercise_date: The options will vest in full upon the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next annual meeting. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 01:58 UTC |
O'HEERON PETEDirector · Chief Executive Officer
|
PurchaseCommon Stock | 8,500 | $1.91 | $16,269.00 |
DisclosureSEC source: 0001493152-24-031439 · ownership.xml · nonDerivative · entry 1 O'HEERON PETE · CIK 0001569334 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,056,647 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiples transactions ranging from $1.82 to $2.017 on August 12, 2024. The reporting person will provide upon request to the SEC, the issuer, or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 12, 2024 Filed Aug 13, 2024 01:58 UTC |
Khoja HamidChief Scientific Officer
|
PurchaseCommon Stock | 10,000 | $1.90 | $19,000.00 |
DisclosureSEC source: 0001493152-24-031438 · ownership.xml · nonDerivative · entry 1 Khoja Hamid · CIK 0002010662 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,250 Read SEC document |
| March 01, 2024 Filed Mar 8, 2024 21:14 UTC |
GARCIA RUBEN AGeneral Counsel
|
GrantStock Option (Right to Buy) · Derivative | 180,000 | $0.00 Strike: $13.00 | $0.00 |
DisclosureSEC source: 0001493152-24-009398 · ownership.xml · derivative · entry 1 GARCIA RUBEN A · CIK 0002013617 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 180,000 Underlying: Common Stock · 180,000 shares Expires 2034-02-28 F1 · derivative.exercise_date: On March 1, 2024, the reporting person was granted an option to purchase 180,000 shares of common stock. One fourth (1/4th) of the option shares shall vest on the one year anniversary of the grant date, and the remaining balance of the option shares shall vest in 36 equal consecutive monthly installments thereafter until fully vested so long as the reporting person remains in continuous service through such applicable vesting periods. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.